Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Depreciation and Depletion (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Depreciation and Depletion for 12 consecutive years, with $256995.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation and Depletion fell 56.6% year-over-year to $256995.0, compared with a TTM value of $899840.0 through Sep 2025, down 63.96%, and an annual FY2024 reading of $2.2 million, down 14.19% over the prior year.
  • Depreciation and Depletion was $256995.0 for Q3 2025 at China Pharma Holdings, up from $163503.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $966956.0 in Q3 2021 and bottomed at $163503.0 in Q2 2025.
  • Average Depreciation and Depletion over 5 years is $579276.7, with a median of $634260.0 recorded in 2024.
  • The sharpest move saw Depreciation and Depletion skyrocketed 45.54% in 2021, then plummeted 74.22% in 2025.
  • Year by year, Depreciation and Depletion stood at $701100.0 in 2021, then fell by 10.03% to $630781.0 in 2022, then rose by 0.44% to $633577.0 in 2023, then crashed by 51.43% to $307741.0 in 2024, then dropped by 16.49% to $256995.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for CPHI at $256995.0 in Q3 2025, $163503.0 in Q2 2025, and $171601.0 in Q1 2025.